Introduction
Human heat-shock proteins (HSPs) function as molecular chaperons in general and are reported to be produced by macrophages (Mφ), vascular endothelial cells, smooth muscle cells, endometrial cells and other dendritic cells [1, 2] . Molecular chaperons are critical for the folding and regulation of a wide array of cellular proteins (3) . Heat shock proteins are the most representative group of chaperons. As a marker of tissue stress reaction, endogenous HSPs including HSP70 may be released under a wide variety of stressful stimuli such as heat shock, viral or bacterial infections, internal physical stress, chemical stress and pelvic inflammation [4, 5] . Endometrial tissue breakdown during menstruation and neurogenic or painful stimuli may also elicit a stressful reaction to the tissues.
Most of the published reports on HSPs described their expression in either endometrium or in endometriosis. A prominent stress reaction in the pelvis of women with endometriosis and the role of HSP70 in Toll-like receptor (TLR) 4-mediated inflammation and growth of endometriosis has been recently reported from our laboratory [6] . Persistent and changing inflammatory reaction in pelvic environment and Khan KN et al., Page 6 growth/invasion of cells may induce variable stress reaction in tissues derived from women with endometriosis. An additive effect between HSP70 and inflammation has been observed in a recent study [7] . Despite enough information on endometriosis, the detailed analysis of HSP70 immunoreactivity in adenomyosis or in uterine myoma is limited.
The hyperplastic and/or hypertrophic changes of smooth muscle cells in response to the invaginating glands/stroma into the myometrium of patients with adenomyosis may exert stressful insult to the adenomytic lesions or to the surrounding myometrium. A similar pattern of tissue stress reaction may occur in the endometrium or myometrium in response to the growing myoma nodules. A differential inflammatory reaction in submucosal, intramural and subserosal myomas has been reported [8] .
However, the tissue stress reaction and its association with tissue inflammatory reaction in women with adenomyosis and uterine myoma are yet to be investigated.
In addition to pituitary suppression, we recently demonstrated that GnRHa has multiple biological functions in peripheral tissues of women with different reproductive diseases [9] . Since, GnRH receptors were expressed by both eutopic endometria and Khan KN et al., Page 7 pathological lesions of women with endometriosis, adenomyosis, and uterine myoma [9] , we believe that multiple biological functions could be the direct tissue effect of GnRHa or indirect effect of GnRHa-mediated estrogen suppression. In fact, GnRHa was able to significantly suppress tissue inflammatory reaction, angiogenesis, cell proliferation and induced apoptosis in women with endometriosis, adenomyosis and uterine myoma [9] . In a separate study, suppression of HSP70 expression in response to GnRHa and in women with endometriosis has been recently reported [10] . However, the role of GnRHa in the tissue expression of HSP70 in women with adenomyosis and uterine myoma is unknown.
Therefore, in the first part of our study, we aim to examine the tissue expression of human HSP70 in pathological lesions and endometria derived from GnRHa-untreated women with adenomyosis and uterine myomas. We speculated that infiltrating immune cells and micro-vessels within tissues might also suffer a variable amount of stress reaction. Therefore, secondly, we examined the co-localization of HSP70 and CD68 (Mφ marker) and von Willebrand factor (VWF, vessel marker) in the serial section of tissues derived from these women. Finally, we compared the pattern 
Materials and Methods
Subjects. This is a case-controlled biological research using prospectively collected biopsy samples of women with and without adenomyosis/uterine myoma and their retrospective evaluation. The subjects in this study were women of reproductive age (age range 23-51yrs). From July 2009 to April 2012, biopsy specimens were collected from a total of 30 women with adenomyosis and 35 women with uterine myomas who underwent laparoscopy, laparotomy or hysteroscopy. All these fertile women were admitted to our hospital with the complaint of pelvic pain, dysmenorrhea, abnormal genital bleeding, hypermenorrhoea or anemia. The control group consisted of 15 fertile women between 23 and 37 years of age without any evidence of peritoneal or ovarian endometriosis and operated on for dermoid cysts by laparoscopy. We selected patients with dermoid cysts as control group with the assumption that tissues of these patients may suffer less stress reaction (but not zero) than in tissues derived from other Khan KN et al., Page 9 reproductive diseases as demonstrated recently [6, 11] . The diagnosis of adenomyosis and uterine fibroids in all these women was done by clinical manifestations, by ultrasonograghapy or magnetic resonance image before operation and subsequently confirmed by surgery and histopathology. The distribution of women who had GnRHa treatment for a period of 3-6 months is as follows: adenomyosis (n=14) and uterine myoma (n=20). Groups of women without GnRHa treatment in this study did not receive oral contraceptives or any other hormonal medication within 12 months prior to surgery. The phases of the menstrual cycle in women without hormonal therapy was determined by histological dating of eutopic endometrial samples taken simultaneously with pathological lesions derived from these women. Immunohistochemistry. Details of immunohistochemical procedures are described elsewhere [13, 16] . Briefly, 5μm thick paraffin embedded tissues were deparaffinized in xylene and rehydrated in phosphate buffered saline (PBS). After immersion in 0.3% H 2 O 2 / methanol to block endogenous peroxidase activity, sections were pre-incubated with 10% normal goat serum to prevent non-specific binding and then incubated overnight at room temperature with respective antibody. The slides were subsequently incubated with biotinylated second antibody for 10 min, followed by incubation with avidin-peroxidase for 10 min and visualized with diaminobenzidine.
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Finally, the tissue sections were counterstained with Mayers hematoxylin, dehydrated with serial alcohols, cleared in xylene and mounted.
All immunoreactive cells and tissues were examined in five different fields of one section (x200 or x400) by light microscopy. Mφ numbers as immunoreactive to CD68 and total micro-vessel numbers as immunoreactive to VWF were counted. Total micro-vessel density of those areas that contained the highest number of capillaries and venules was analyzed. The intensity of HSP70-stained cells and numbers of CD68-stained Mφ per field in each biopsy specimen were examined and confirmed by a second observer (MK). of one section by light microscopy at moderate magnification (×200). The authors were blinded to the study groups during quantification.
As a main outcome measures, we investigated the pattern of changes in the tissue of expression of HSP70 in respective biopsy samples derived from GnRHa-treated and -untreated women with adenomyosis and uterine myoma. We also evaluated a panel of confounding variables such as, age, parity, phases of the menstrual cycle, severity of symptoms, presence of adenomyotic lesion/myoma nodule, and GnRHa treatment that might be involved as a potential source of tissue stress reaction and in the tissue expression of HSP70.
Statistical Analysis. The clinical characteristics of the subjects were evaluated by one-way analysis of variance. All results are expressed as either mean ± SD or median and inter-quartile range (IQR). The differences between study group and control group, GnRHa-treated and -untreated group were compared using Mann-Whitney U-test or Student's t test. For comparison among groups, the Kruskal-Wallis test was used.
Pearson's correlation coefficient was used to evaluate the relationship between two groups. Multiple analysis of covariance (ANCOVA) was performed to evaluate possible 
Results
The clinical profiles of control women, GnRHa-treated and -untreated women with adenomyosis and uterine myoma are shown in Table 1 . The women with adenomyosis and uterine myoma were significantly older than control women (p<0.01 for each). No age difference was observed between women with adenomyosis and uterine myoma or between GnRHa-treated and -untreated women (Table 1) . We did not find any influence of age difference in the tissue expression of HSP70. There was no difference in the number of women presenting with pain, anemia, reproductive desire or body mass index among study groups (data not shown). The distribution in the phases of menstrual cycle in GnRHa-untreated women and type of uterine myomas are shown in Table 1 . 
Q-H scores of HSP70-immunoreactivity in adenomyosis and uterine myoma.
Since there was no significant difference in HSP70 expression between gland cells and stromal cells, we represented combined data of Q-H scores of gland/stromal cells in the eutopic endometria or pathological lesions derived from control women and women with adenomyosis/uterine myoma (Figure 1, B) . We found that Q-H scores of HSP70 immunoreaction were significantly higher in the eutopic endometria/adenomyotic Khan KN et al., Page 16 lesions, eutopic endometria/myoma nodules and autologous myometria derived from women with adenomyosis and uterine myoma when compared with that of control endometria (p<0.05 for each of endometria, lesions and myometria) (Figure 1, B) .
There was no obvious difference in the Q-H scores of HSP70 immunoreaction between adenomyotic lesions and myoma nodules or between surrounding myometria derived from women with adenomyosis and uterine myoma (Figure 1, B) .
Co-localization of HSP70 with CD68-positive Mφ and VWF-positive micro-vessels.
To identify co-localization of HSP70, CD68-stained Mφ, and VWF-stained micro-vessels, we extended our experiment using serial sections of each specimen derived from eutopic endometria and myometria of women with adenomyosis and uterine myoma. We found that HSP70 immunostaining was co-localized with VWF-stained micro-vessels and CD68-stained infiltrating Mφ in the parallel section of biopsy specimens derived from the eutopic endometria (Figure 2, A The changes in the immunoreactivity of HSP70 expression in endometria, pathological lesions and myometria derived from GnRHa-treated and -untreated women with adenomyosis and uterine myoma are summarized in Table 2 . Multiple ANCOVA with possible confounding variables as shown in Table 3 revealed that presence of adenomyotic lesions and myoma nodules were significantly and independently associated with the increased tissue expression of HSP70. Age was not an independent risk factor in increasing tissue expression of HSP70 in these two groups of women. This Khan KN et al., Page 19 difference in the tissue expression of HSP70 disappeared after GnRHa treatment (Table   3) .
Discussion
We demonstrated a variable degree of tissue stress reaction in the pathological lesions and eutopic endometria or autologous myometria derived from women with adenomyosis and uterine myoma. This was demonstrated by the over-expression of HSP70 in pathological lesions and eutopic endometria or myometria derived from these two groups of women. Similar to our previous in vitro study in women with endometriosis [6, 7] , here we further confirmed a significant association between stress reaction and inflammation and between stress reaction and angiogenesis in intact tissues derived from women adenomyosis. However, this association was not observed in control women and in women with uterine myoma. Our co-localization study confirmed that infiltrating Mφ and micro-vessels in tissues derived from these women also suffer from a variable amount of stress reaction. [1, 6, 19] . We previous reported decreased levels of cell proliferation, inflammation and angiogenesis in tissues derived from control women than in women with endometriosis [14, 16] . A decreasing order of tissue inflammation, angiogenesis, and prostaglandin production was observed in submucosal myoma, intramural myoma, and in subserosal myoma [8] . Here, we did not separately analyze the pattern of HSP70 expression in each of these three types of uterine myoma due to small sample size. This could explain the reason why we did not find any positive association between HSP70 expression and CD68-positive Mφ or between HSP70 and VWF-positive micro-vessels in tissues derived from women with uterine myoma. Further studies using individual types of uterine myoma may clarify our findings.
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Several reports have shown that heat shock proteins vary in accordance with the menstrual cycle. Tabibzadeh et al., [20] reported that constitutive form of HSP70 in human endometrium increased progressively during the late proliferative and early secretory phases, and diminished in the mid-to late secretory phases. Koshiyama et al., [21] found a markedly increased expression of HSP70 in human endometrium during the secretory phase. In our recent study in women with endometriosis [10] , we found the highest expression of HSP70 in the menstrual phase, intermediate expression in the secretory phase and lower expression in the proliferative phase. In our present study, we did not find any significant difference in the tissue expression of HSP70 between the secretory phase and the proliferative phase of any of the control or study groups. This could be due to the difference in sample number or in our Q-H scoring system. Increased HSP70 protein expression in the endometria and pathological lesions of women with adenomyosis and uterine myoma carries some biological significance: (1) As a molecular chaperon, HSP70 inhibits apoptosis of host cells by preventing recruitment of caspases to the apoptosome complex [22] . Therefore, increased expression of HSP70 may contribute to increased survival of This may also result in increasing cytokine levels by M φ or increase in cell proliferation as we reported recently [7] .
An interesting finding in our current study is that treatment with GnRHa was able to significantly suppress tissue expression of HSP70 in the pathological lesions, endometria and autologous myometria when compared with similar tissues derived GnRHa may decrease tissue inflammation secondary to decreased levels of tissue stress reaction either directly or indirectly by causing estrogen suppression. In fact, HSP70/estrogen-induced inflammatory and pro-inflammatory response has been recently demonstrated [6, 7, 23] . This may further explain the therapeutic benefit of GnRHa in alleviating pain manifestation or in improving reproductive outcome in women with adenomyosis and uterine myoma.
There are some limitations in our current findings: (1) 
